Hint mode is switched on Switch off

WDNA - WisdomTree BioRevolution Fund (USD) (US97717Y6187)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US97717Y6187
WDNA ISIN
Exchange Traded Funds (ETF)
Type of fund
WisdomTree
Provider
17.87 USD
NAV per Share | 03/06/2026
03/06/2021
Inception Date
1 times per year
Dividend payments
CIOJLS
CFI
WDNA
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
WisdomTree BioRevolution Index
Benchmark
0.45 %
Total Cost Ratio
2.32 mln USD
Fund NAV | 03/06/2026
2.32 mln USD
Share Class NAV | 03/06/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 04/06/2026, Cboe BZX Exchange

  • YTD
    0.79 %
  • 1M
    -8.27 %
  • 3M
    -5.5 %
  • 6M
    7.76 %
  • 1Y
    43.78 %
  • 3Y
    5.21 %
  • 5Y
    -
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (WDNA)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index.

WDNA profile

The WisdomTree BioRevolution Fund (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The WisdomTree fund’s base currency is USD and the share class was registered 03.06.2021 with unique ISIN - US97717Y6187. Main exchange is Cboe BZX Exchange and ticker symbol is WDNA. The total expense ratio is 0.45%. The WisdomTree BioRevolution Fund (USD) pays dividends 1 time(s) per year.

Structure WDNA on 14/05/2026

Download structure in Excel
Paper Value
Eli Lilly & Co 3.98%
Twist Bioscience Corp 3.56%
Moderna Inc 3.44%
Johnson & Johnson 3.14%
United Therapeutics Corp 3.03%
Immunome Inc 2.73%
Darling Ingredients Inc 2.59%
Stoke Therapeutics Inc 2.33%
Corteva Inc 2.28%
Beam Therapeutics Inc 2.09%
Tempus Ai Inc 2.08%
ASTRAZENECA PLC 2.07%
Isis Pharmaceuticals Inc 2.06%
Bunge Global Sa 2.02%
Natera Inc 1.96%
Krystal Biotech Inc 1.94%
Crispr Therapeutics Ag 1.9%
Gilead Sciences Inc 1.84%
Structure Therapeutics Inc 1.83%
Roivant Sciences Ltd 1.68%
Arrowhead Pharmaceuticals Inc 1.68%
Pfizer Inc 1.67%
Amgen Inc 1.66%
Thermo Fisher Scientific Inc 1.58%
Revolution Medicines Inc 1.56%
Novozymes A/S 1.49%
Novartis AG 1.47%
Bayer AG 1.44%
Agios Pharmaceuticals Inc 1.41%
Vertex Pharmaceuticals Inc 1.41%
Catalyst Pharmaceuticals Inc 1.24%
10X Genomics Inc-Class A 1.18%
Exelixis Inc 1.14%
Veracyte Inc 1.13%
Verbio AG 1.1%
Cullinan Therapeutics Inc 1.07%
Protagonist Therapeutics Inc 1.03%
Cg Oncology Inc 1.03%
Biontech Se-ADR 1.01%
Allogene Therapeutics Inc 0.98%
Celldex Therapeutics Inc 0.98%
Editas Medicine Inc 0.98%
Biohaven Ltd 0.97%
Argenx Se - Adr 0.96%
Dyne Therapeutics Inc 0.96%
ABSCI Corp 0.95%
Viking Therapeutics Inc 0.88%
Uniqure NV 0.86%
Biogen Idec Inc 0.85%
FMC Corp 0.8%
Iovance Biotherapeutics Inc 0.76%
Danaher Corp 0.75%
Arcturus Therapeutics Hlgs 0.74%
Insmed Inc 0.73%
Green Plains Inc 0.73%
Merck & Co Inc/NJ 0.72%
Regeneron Pharmaceuticals Inc 0.71%
Sana Biotechnology Inc 0.7%
Halozyme Therapeutics Inc 0.67%
Syensqo Sa 0.64%
Repligen Corp 0.64%
Regenxbio Inc 0.56%
Ultragenyx Pharmaceutical Inc 0.54%
Nufarm Ltd/Australia 0.53%
Bridgebio Pharma Inc 0.52%
Illumina Inc 0.51%
Intellia Therapeutics Inc 0.48%
Genmab A/S -Sp ADR 0.48%
BioMarin Pharmaceutical Inc 0.47%
Oxford Nanopore Technologies 0.47%
Genus Plc 0.44%
Zoetis Inc 0.44%
Geron Corp 0.42%
Tyson Foods Inc 0.4%
Techne Corp 0.36%
Rocket Pharmaceuticals Inc 0.34%
Sarepta Therapeutics Inc 0.34%
Alnylam Pharmaceuticals Inc 0.33%
QIAGEN N.V. 0.25%
Pacific Biosciences Of Calif 0.22%
US DOLLAR 0.08%
DREYFUS TRSY OBLIG CASH MGMT CL INS 0.04%
EURO 0%
AUSTRALIAN DOLLAR 0%
SWISS FRANC 0%
GREAT BRITISH POUND 0%
DANISH KRONE 0%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.